Posted in | News | Materials Analysis

Renishaw Wins Queen's Award for it's inVia Ultra-Fast Raman Imaging Microscope

Renishaw, the global engineering technologies company, is delighted to announce that it has received a Queen’s Award for Enterprise 2014 in the Innovations category for its inVia Raman microscope.

This prestigious Award has been granted for the continuous development of the inVia, with ultra-fast Raman imaging, which enables the rapid generation of high definition 2D and 3D chemical images for material analysis. This is the company’s seventeenth Queen’s Award since its formation in 1973 and its eighth in just eleven years.

Sir David McMurtry, Renishaw’s Chairman and Chief Executive, said:

“Although we have won many Queen’s Awards, this is very special as it is the first to recognise our achievements outside the field of industrial metrology.

"We are now benefitting from a long term commitment to the development of the inVia system which has become the Raman analysis system of choice for many of the world’s most prestigious research institutions, and a contributor to global research in an exciting range of advanced materials applications such as graphene.

"Congratulations to all the Renishaw staff around the world that have contributed to the success of this internationally acclaimed research system.”

Renishaw’s inVia microscopes use a form of light scattering (Raman scattering) to analyse the chemical structure and composition of materials. It is of major benefit to academics and industrialists who use inVia to tackle analytical problems across a broad range of application areas, including: chemicals; materials science; pharmaceuticals; semiconductors; forensics; gemmology; antiquities; and green energy development, such as photovoltaics.

inVia’s StreamLine™ technology enables users to generate chemical images rapidly and it has opened up new research opportunities in many fields, including biology and nanotechnology. StreamLine scans the sample with a line of laser light, collecting data from multiple points simultaneously. This prevents sample damage and gives shorter analysis times.

StreamLine is made possible by a Renishaw-developed motorised sample stage, which provides fast, accurate motion, and enables the imaging of both small and large areas. StreamLine’s performance is significantly superior to previous imaging techniques, allowing users to improve efficiency and reduce costs.

The Queen’s Awards for Enterprise are made each year by Her Majesty The Queen, on the advice of the British Prime Minister, who is assisted by an Advisory Committee that includes representatives of Government, industry and commerce, and the trade unions. The Awards are given solely on merit and competition is fierce. The number of Awards presented each year is not pre-set and depends on the quality of the applications received.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Renishaw plc - Spectroscopy. (2019, February 08). Renishaw Wins Queen's Award for it's inVia Ultra-Fast Raman Imaging Microscope. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=40899.

  • MLA

    Renishaw plc - Spectroscopy. "Renishaw Wins Queen's Award for it's inVia Ultra-Fast Raman Imaging Microscope". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=40899>.

  • Chicago

    Renishaw plc - Spectroscopy. "Renishaw Wins Queen's Award for it's inVia Ultra-Fast Raman Imaging Microscope". AZoM. https://www.azom.com/news.aspx?newsID=40899. (accessed November 21, 2024).

  • Harvard

    Renishaw plc - Spectroscopy. 2019. Renishaw Wins Queen's Award for it's inVia Ultra-Fast Raman Imaging Microscope. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=40899.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.